Table 3.
Incidence of laboratory and radiographical abnormalities, stratified by age.
| All ages | 20 to 29 years | 30 to 39 years | 40 to 49 years | ≥50 years | P-value | |
|---|---|---|---|---|---|---|
| Renal panel (n = 201) | ||||||
| Hyponatremia, n (%) | 5 (2.5) | 0 (0.0) | 0 (0.0) | 2 (1.74) | 3 (4.9) | 0.0557 |
| Hypokalemia, n (%) | 20 (10.0) | 0 (0.0) | 2 (10.0) | 10 (8.7) | 8 (13.1) | 0.0111 |
| Liver function test (n = 197) | ||||||
| Transaminitis, n (%) | 46 (23.4) | 3 (75.0) | 5 (27.8) | 22 (19.3) | 16 (26.2) | <0.0001 |
| ALT >2 times ULN, n (%) | 7 (3.6) | 0 (0.0) | 0 (0.0) | 4 (3.5) | 3 (5.0) | 0.0527 |
| Full blood count (n = 201) | ||||||
| All disorders, n (%) | 44 (21.9) | 0 (0.0) | 3 (15.0) | 29 (25.2) | 12 (19.6) | <0.0001 |
| Thrombocytopenia, n (%) | 8 (4.0) | 0 (0.0) | 0 (0.0) | 7 (6.1) | 1 (1.6) | 0.0151 |
| Leukopenia, n (%) | 8 (4.0) | 0 (0.0) | 0 (0.0) | 7 (6.1) | 1 (1.6) | 0.0151 |
| Anemia, n (%) | 8 (4.0) | 0 (0.0) | 0 (0.0) | 5 (4.4) | 3 (4.9) | 0.0418 |
| Polycythemia, n (%) | 4 (2.0) | 0 (0.0) | 0 (0.0) | 2 (1.7) | 2 (3.3) | 0.1834 |
| Microcytosis, n (%) | 15 (7.5) | 0 (0.0) | 3 (15.0) | 7 (6.1) | 5 (8.2) | 0.0015 |
| Macrocytosis, n (%) | 1 (0.5) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 0 (0.0) | 0.6213 |
| Chest X-ray (n = 226) | ||||||
| Infective changes, n (%) | 20 (8.9) | 0 (0.0) | 2 (6.9) | 8 (6.7) | 10 (16.4) | 0.0010 |
| Atelectasis, n (%) | 6 (2.7) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 5 (8.2) | 0.0004 |
| Nodules, granulomata, n (%) | 5 (2.2) | 0 (0.0) | 0 (0.0) | 5 (4.2) | 0 (0.0) | 0.0391 |
| Pleural thickening/scarring, n (%) | 3 (1.3) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 2 (3.3) | 0.1268 |
Data are number of patients (percentage of the total number of patients tested in each group). P-values are calculated by comparing all four age groups using chi–square tests. ALT, alanine aminotransferase; ULN, upper limit of normal.